Last reviewed · How we verify

NCT06245525: PCLAW

Survey on Palliative Care and Law Perception

Completed Last updated 23 January 2025
What this trial tests

trial testing This is not an interventional study in End of Life in 523 participants. Completed in 8 January 2025.

Timeline
22 April 2024
Primary endpoint
8 January 2025
8 January 2025

Quick facts

Lead sponsorUniversity of Athens
StatusCompleted
Study typeOBSERVATIONAL
Enrollment523
Start date22 April 2024
Primary completion8 January 2025
Estimated completion8 January 2025
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

University of Athens

Who can join

Eligibility, any sex, with End of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the current survey study is to obtain detailed information about European intensive care unit (ICU) clinicians' awareness of palliative care and relevant, local end-of-life (EoL) legislation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. ESICM LIVES 2025
    · 2025

Verify or expand the search:

Other trials of This is not an interventional study

Trials testing the same drug.

Other recruiting trials for End of Life

Currently open trials in the same condition.

Other University of Athens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06245525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing